Article
Clinical Validation of a 106-SNV MALDI-ToF MS Pharmacogenomic Panel.
The journal of applied laboratory medicine - 1 May 2020
Williams Grace R, Cook Leanne, Lewis Lionel D, Tsongalis Gregory J, Nerenz Robert D
Abstract excerpt
BACKGROUND: Laboratorians have the opportunity to help minimize the frequency of adverse drug reactions by implementing pharmacogenomic testing and alerting care providers to possible patient/drug incompatibilities before drug treatment is initiated. Methods combining PCR with MALDI-ToF MS have allowed for sensitive, economical, and multiplexed pharmacogenomic testing results to be delivered in a timely fashion....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.